Cardio-Cerebral And Peripheral Vascular Health

Cardiovascular and cerebrovascular diseases are the top killers of human health. Data show that there were about 290 million patients with cardiovascular diseases in China, and nearly 4 million patients died of cardiovascular diseases in China in 2016. In addition to the risk of death, the high incidence and disability rate of cardiovascular diseases bring heavy economic burden and psychological burden to the society, families and individual patients.
Tide Pharmaceutical has China's first international high-end lipid microsphere carrier targeted drug “Alprostadil Injection” - “Kaishi   and oral prostacyclin (PGI2) derivatives - Kaina   ”, which can effectively treat cardiovascular, cerebrovascular and peripheral vascular diseases and improve clinical symptoms and prognosis through multiple pharmacological effects such as dilating blood vessels as well as improving circulation and anti-platelet aggregation.

Kaina    (Beraprost Sodium Tablets)

Kaishi    (Alprostadil Injection)

【Indications】
To improve ulcers, intermittent claudication, pain, cold sensation and other symptoms caused by chronic arterial occlusive disease.
【Description】
This product of 20 µg is white to off-white film-coated tablet, engraved with "BS20" on one side, which is white after removing the coating; this product of 40 µg is yellowish film-coated tablet, engraved with "BS40" on one side, which is white after removing the coating.
【Strength】
(1) 20 µg; (2) 40 µg
【Dosage and Administration】
Usually, adults take it orally after meals. 40 μg at a time, three times a day.

【Indications】

1. To treat limb ulcers caused by chronic arterial occlusion (thromboangiitis obliterans, occlusive arteriosclerosis, etc.) and rest pain in the limbs caused by microvascular circulation disorders, and improve microcirculation disturbance of cardio cerebral vessels.

2. To inhibit intravascular thrombosis after transplantation as antithrombotic therapy after organ transplantation.

3. To relieve hypoxemia and maintain catheter blood flow before surgical treatment of arterial catheter-dependent congenital heart disease.

4. Adjuvant therapy of chronic hepatitis.
【Description】
This product is white emulsion liquid.
【Strength】
(1) 1ml: 5 μg  (2) 2 ml: 10 μg.
【Dosage and Administration】
Once a day for adults, by slow intravenous injection of 1-2 ml (5-10 μg of alprostadil) + 10 ml of normal saline (or 5% glucose) or by slow intravenous drip infusion through Murphy’s dropper.

®

®

®

®

KEY PRODUCTS